Review Article
A Review of NEPA, a Novel Fixed Antiemetic Combination with the Potential for Enhancing Guideline Adherence and Improving Control of Chemotherapy-Induced Nausea and Vomiting
Table 3
Cycle 1 Efficacy of NEPA + DEX compared with oral palonosetron + DEX.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 value from logistic regression versus oral palonosetron; not adjusted for multiple comparisons. 2 value from two-sided Cochran-Mantel-Haenszel test including treatment, age class, and region as strata. HEC: highly emetogenic chemotherapy; AC: anthracycline cyclophosphamide; NEPA: netupitant/palonosetron; PALO: palonosetron; DEX: dexamethasone. |